200 related articles for article (PubMed ID: 33123141)
1.
Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L
Front Immunol; 2020; 11():569104. PubMed ID: 33123141
[TBL] [Abstract][Full Text] [Related]
2.
Song J; Dai J; Chen X; Ding F; Ding Y; Ma L; Zhang L
Histol Histopathol; 2024 May; 39(5):623-632. PubMed ID: 37916940
[TBL] [Abstract][Full Text] [Related]
3. Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.
Yang H; Liu Q; Liu H; Kang X; Tian H; Kang Y; Li L; Yang X; Ren P; Kuang X; Wang X; Guo L; Tong M; Ma J; Fan W
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466881
[TBL] [Abstract][Full Text] [Related]
4. The microbiota-gut-brain axis: A crucial immunomodulatory pathway for Bifidobacterium animalis subsp. lactis' resilience against LPS treatment in neonatal rats.
Lin Y; Xie Z; Li Z; Yuan C; Zhang C; Li Y; Xie K; Wang K
Int J Biol Macromol; 2024 May; 266(Pt 2):131255. PubMed ID: 38556221
[TBL] [Abstract][Full Text] [Related]
5. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation.
Iljazovic A; Roy U; Gálvez EJC; Lesker TR; Zhao B; Gronow A; Amend L; Will SE; Hofmann JD; Pils MC; Schmidt-Hohagen K; Neumann-Schaal M; Strowig T
Mucosal Immunol; 2021 Jan; 14(1):113-124. PubMed ID: 32433514
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.
Kim S; Goel R; Kumar A; Qi Y; Lobaton G; Hosaka K; Mohammed M; Handberg EM; Richards EM; Pepine CJ; Raizada MK
Clin Sci (Lond); 2018 Mar; 132(6):701-718. PubMed ID: 29507058
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
Front Immunol; 2020; 11():1390. PubMed ID: 32733460
[No Abstract] [Full Text] [Related]
8. Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers.
Shalapour S; Karin M
Annu Rev Immunol; 2020 Apr; 38():649-671. PubMed ID: 32040356
[TBL] [Abstract][Full Text] [Related]
9. Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function.
Schreiber F; Balas I; Robinson MJ; Bakdash G
Cells; 2024 Mar; 13(6):. PubMed ID: 38534321
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier.
Liu Y; Huang W; Wang J; Ma J; Zhang M; Lu X; Liu J; Kou Y
Front Immunol; 2021; 12():693479. PubMed ID: 34386004
[TBL] [Abstract][Full Text] [Related]
11. Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro.
De Giani A; Perillo F; Baeri A; Finazzi M; Facciotti F; Di Gennaro P
PLoS One; 2024; 19(4):e0301822. PubMed ID: 38603764
[TBL] [Abstract][Full Text] [Related]
12. Human menstrual blood-derived stem cells alleviate autoimmune hepatitis via JNK/MAPK signaling pathway in vivo and in vitro.
Zhang F; Xiao L; Yang Y; Zhou M; Zhao Y; Xie Z; Ouyang X; Ji F; Tang S; Li L
Front Med; 2023 Jun; 17(3):534-548. PubMed ID: 37010727
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 family cytokines at the crossroads of microbiome regulation in barrier health and disease.
Narros-Fernández P; Chomanahalli Basavarajappa S; Walsh PT
FEBS J; 2024 May; 291(9):1849-1869. PubMed ID: 37300849
[TBL] [Abstract][Full Text] [Related]
14. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.
Plaza-Díaz J; Solís-Urra P; Rodríguez-Rodríguez F; Olivares-Arancibia J; Navarro-Oliveros M; Abadía-Molina F; Álvarez-Mercado AI
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171747
[TBL] [Abstract][Full Text] [Related]
15. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages
Zhang H; Liu M; Zhong W; Zheng Y; Li Y; Guo L; Zhang Y; Ran Y; Zhao J; Zhou L; Wang B
Front Immunol; 2021; 12():624360. PubMed ID: 33841405
[TBL] [Abstract][Full Text] [Related]
16. Probiotic supplementation in marathonists and its impact on lymphocyte population and function after a marathon: a randomized placebo-controlled double-blind study.
Batatinha H; Tavares-Silva E; Leite GSF; Resende AS; Albuquerque JAT; Arslanian C; Fock RA; Lancha AH; Lira FS; Krüger K; Thomatieli-Santos R; Rosa-Neto JC
Sci Rep; 2020 Nov; 10(1):18777. PubMed ID: 33139757
[TBL] [Abstract][Full Text] [Related]
17. Association Between Pulse Pressure and Carotid Intima-Media Thickness Among Low-Income Adults Aged 45 Years and Older: A Population-Based Cross-Sectional Study in Rural China.
Liu J; Lin Q; Guo D; Yang Y; Zhang X; Tu J; Ning X; Song Y; Wang J
Front Cardiovasc Med; 2020; 7():547365. PubMed ID: 33263005
[TBL] [Abstract][Full Text] [Related]
18. Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability.
Liu Q; Tian H; Kang Y; Tian Y; Li L; Kang X; Yang H; Wang Y; Tian J; Zhang F; Tong M; Cai H; Fan W
J Nutr Biochem; 2021 Dec; 98():108863. PubMed ID: 34517094
[TBL] [Abstract][Full Text] [Related]
19. Implications of gut microbiota in autoimmune liver diseases.
Qian Q; He W; Tang R; Ma X
Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160
[TBL] [Abstract][Full Text] [Related]
20. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
[Next] [New Search]